TransCode Therapeutics, Inc. (RNAZ)
1.86
+0.15
(+8.77%)
USD |
NASDAQ |
Oct 09, 16:00
1.895
+0.04
(+1.88%)
After-Hours: 20:00
TransCode Therapeutics EPS Diluted (Quarterly) : -7.172 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.172 |
| March 31, 2026 | -21.28 |
| December 31, 2025 | -16.42 |
| September 30, 2025 | -5.825 |
| June 30, 2025 | -5.130 |
| March 31, 2025 | -70.16 |
| December 31, 2024 | -160.96 |
| September 30, 2024 | -5.217 |
| June 30, 2024 | -24.29 |
| March 31, 2024 | -21.35 |
| December 31, 2023 | -214.98 |
| September 30, 2023 | -2215.87 |
| June 30, 2023 | -4343.21 |
| March 31, 2023 | -8830.80 |
| Date | Value |
|---|---|
| December 31, 2022 | -10444.37 |
| September 30, 2022 | -8726.52 |
| June 30, 2022 | -9502.94 |
| March 31, 2022 | -7059.36 |
| December 31, 2021 | -5726.69 |
| September 30, 2021 | -4765.99 |
| June 30, 2021 | 5668.61 |
| March 31, 2021 | -9176.11 |
| December 31, 2020 | -1639.70 |
| September 30, 2020 | -2810.81 |
| June 30, 2020 | -260.30 |
| March 31, 2020 | -84.48 |
| December 31, 2019 | -400.22 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.750M |
| Total Expenses (Quarterly) | 6.750M |
| Enterprise Value | 160.20M |
| Earnings Yield | -2.73K% |
| Normalized Earnings Yield | -2005.59 |